Acutus Medical Inc Quick Ratio (AFIB) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Acutus Medical Inc   (AFIB)

Acutus Medical Inc 's Quick Ratio

AFIB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Acutus Medical Inc 's Cash & cash equivalent grew by 11.31 % in the Q4 2024 sequentially, while Current Liabilities decreased, this led to improvement in Acutus Medical Inc 's Quick Ratio to 1.13, Quick Ratio remained below Acutus Medical Inc average.

Within Medical Equipment & Supplies industry 126 other companies have achieved higher Quick Ratio than Acutus Medical Inc in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 1869 to 2186.

Explain Quick Ratio?
How much Cash & cash equivalents AFIB´s has?
What are AFIB´s Current Liabilities?




AFIB Quick Ratio (Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
Y / Y Current Liabilities Change -34.34 % -0.69 % -32.07 % -42.29 % 18.07 %
Y / Y Cash & cash equivalent Change -37.42 % -67.26 % -75.55 % -71.32 % -68.2 %
Quick Ratio MRQ 1.13 0.86 1.08 2.02 1.18
AFIB's Total Ranking # 2186 # 1869 # 1154 # 588 # 1623
Seq. Current Liabilities Change -15.19 % 18.48 % 25.36 % -47.87 % 28.27 %
Seq. Cash & cash equivalent Change 11.31 % -5.49 % -33.21 % -10.93 % -41.77 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 723
Overall Market # 2186


Quick Ratio Statistics
High Average Low
9.8 3.79 0.86
(Sep 30 2020)   (Sep 30 2024)




Financial Statements
Acutus Medical Inc 's Current Liabilities $ 12 Millions Visit AFIB's Balance sheet
Acutus Medical Inc 's Cash & cash equivalent $ 14 Millions Visit AFIB's Balance sheet
Source of AFIB's Sales Visit AFIB's Sales by Geography


Cumulative Acutus Medical Inc 's Quick Ratio

AFIB's Quick Ratio for the trailling 12 Months

AFIB Quick Ratio

(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth -28.51 % -15.55 % -19.71 % -16.71 % -7.21 %
Y / Y Cash & cash equivalent TTM Growth -67.62 % -70.7 % -63.9 % -54.16 % -38.41 %
Quick Ratio TTM 1.21 1.22 1.68 2.19 2.68
Total Ranking TTM # 4221 # 3357 # 2722 # 2675 # 2639
Seq. Current Liabilities TTM Growth -11.64 % -0.18 % -9.45 % -10.48 % 4.38 %
Seq. Cash & cash equivalent TTM Growth -12.28 % -27.49 % -30.43 % -26.83 % -20.62 %


On the trailing twelve months basis In spite of the year on year decrease in AFIB's Current Liabilities to $12.44 millions, cumulative Quick Ratio to 1.21 below the AFIB average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 219 other companies have achieved higher Quick Ratio than Acutus Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 3357 to 4221.

Explain Quick Ratio?
How much Cash & cash equivalents AFIB´s has?
What are AFIB´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 220
Healthcare Sector # 1032
Within the Market # 4221


trailing twelve months Quick Ratio Statistics
High Average Low
4.71 1.71 1.14
(Mar 31 2021)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Quick RatioDec 31 2024 MRQ Cash & cash equivalentDec 31 2024 MRQ Current Liabilities
Vivani Medical Inc   3.07 $ 18.352  Millions$ 5.986  Millions
Inspira Technologies Oxy B H N Ltd  3.01 $ 11.680  Millions$ 3.878  Millions
Aethlon Medical Inc   2.97 $ 5.442  Millions$ 1.830  Millions
Apyx Medical Corp  2.96 $ 31.741  Millions$ 10.721  Millions
Pulmonx Corporation  2.90 $ 70.905  Millions$ 24.437  Millions
Pulsenmore Ltd   2.89 $ 11.270  Millions$ 3.904  Millions
Medigus Ltd   2.86 $ 8.753  Millions$ 3.064  Millions
Nevro Corp   2.84 $ 292.534  Millions$ 102.943  Millions
Adagio Medical Holdings inc   2.65 $ 20.586  Millions$ 7.763  Millions
Safe Pro Group Inc   2.64 $ 1.971  Millions$ 0.747  Millions
Alphatec Holdings Inc   2.54 $ 138.840  Millions$ 54.640  Millions
Cadre Holdings inc   2.53 $ 124.933  Millions$ 49.472  Millions
Dror Ortho-Design, Inc.  2.52 $ 0.549  Millions$ 0.218  Millions
Harvard Apparatus Regenerative Technology Inc   2.43 $ 2.486  Millions$ 1.021  Millions
Nephros Inc   2.41 $ 3.760  Millions$ 1.562  Millions
Tandem Diabetes Care Inc   2.36 $ 438.329  Millions$ 186.120  Millions
Icad Inc  2.35 $ 17.206  Millions$ 7.332  Millions
Longduoduo Co Ltd  2.35 $ 1.084  Millions$ 0.462  Millions
Microbot Medical Inc   2.31 $ 5.519  Millions$ 2.390  Millions
Intuitive Surgical Inc   2.30 $ 4,013.300  Millions$ 1,745.300  Millions
Mimedx Group Inc   2.29 $ 104.416  Millions$ 45.595  Millions
Surmodics Inc   2.29 $ 30.145  Millions$ 13.185  Millions
Staar Surgical Co  2.22 $ 230.494  Millions$ 103.791  Millions
Biolife Solutions Inc   2.22 $ 100.736  Millions$ 45.370  Millions
Treace Medical Concepts Inc   2.17 $ 75.677  Millions$ 34.925  Millions
Beyond Air Inc   2.15 $ 34.468  Millions$ 16.067  Millions
Inogen Inc   2.13 $ 113.795  Millions$ 53.381  Millions
Electromed Inc   2.09 $ 16.080  Millions$ 7.677  Millions
Genedx Holdings Corp   2.07 $ 141.185  Millions$ 68.199  Millions
Orthopediatrics Corp  2.03 $ 68.833  Millions$ 33.962  Millions

Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.